The catastrophic chain of events which took place in March at the Parexel testing unit at Northwick Park Hospital (London) suggests that the clinical trials of the anti-inflammatory drug TGN1412 on six volunteers cannot have been carried out with sufficient precaution.
Katastrofālā notikumu virkne pareksela izmēģinājumu vienībā uz sešiem brīvprātīgajiem martā Northwick Park Hospital (Londonā) norāda uz to, ka pretiekaisuma zāļu TGN1412 klīniskos pētījumus nevar veikt bez pietiekamas piesardzības.